{
    "text_blocks": {
        "data": {
            "block_count": 2,
            "table_index": 0
        },
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "votes": {
                    "0": "0",
                    "1": "0",
                    "2": "0"
                },
                "decision": "0"
            },
            "gpt-4o-2024-08-06": {
                "votes": null,
                "decision": null
            }
        },
        "timestamp": "2025-01-21_09-33-13"
    },
    "table_comments": {
        "data": "CONSOLIDATED BALANCE SHEETS\t(In millions, except shares in thousands and per share data in dollars)\tDecember 31,\t2020\tDecember 31,\t2019\t",
        "timestamp": "2025-03-11_12-18-36"
    },
    "units": {
        "data": {
            "sum_units": 1000000,
            "sum_divider": 1.0
        },
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "votes": {
                    "0": "1000000",
                    "1": "1000000"
                },
                "decision": "1000000"
            },
            "gpt-4o-2024-08-06": {
                "votes": null,
                "decision": null
            }
        },
        "timestamp": "2025-03-11_12-18-39"
    },
    "post_table_text": {
        "data": "\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t66",
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "trials": {
                    "0": "'\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t66'"
                },
                "decision": "'\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t66'"
            },
            "gpt-4o-2024-08-06": {
                "trials": {},
                "decision": null
            }
        },
        "timestamp": "2025-03-11_12-18-41"
    },
    "table_body": {
        "data": "ASSETS\tCurrent assets:\tCash and cash equivalents\t$\t10,800\t$\t12,123\tPremium and trade receivables\t9,696\t6,247\tShort-term investments\t1,580\t863\tOther current assets\t1,317\t1,090\tTotal current assets\t23,393\t20,323\tLong-term investments\t12,853\t7,717\tRestricted deposits\t1,060\t658\tProperty, software and equipment, net\t2,774\t2,121\tGoodwill\t18,652\t6,863\tIntangible assets, net\t8,388\t2,063\tOther long-term assets\t1,599\t1,249\tTotal assets\t$\t68,719\t$\t40,994\tLIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY\tCurrent liabilities:\tMedical claims liability\t$\t12,438\t$\t7,473\tAccounts payable and accrued expenses\t7,069\t4,164\tReturn of premium payable\t1,458\t824\tUnearned revenue\t523\t383\tCurrent portion of long-term debt\t97\t88\tTotal current liabilities\t21,585\t12,932\tLong-term debt\t16,682\t13,638\tDeferred tax liability\t1,534\t189\tOther long-term liabilities\t2,956\t1,543\tTotal liabilities\t42,757\t28,302\tCommitments and contingencies\tRedeemable noncontrolling interests\t77\t33\tStockholders' equity:\tPreferred stock, $\t0.001\tpar value; authorized\t10,000\tshares;\tno\tshares issued or outstanding at December 31, 2020 and December 31, 2019\t \t \tCommon stock, $\t0.001\tpar value; authorized\t800,000\tshares;\t598,249\tissued and\t581,479\toutstanding at December 31, 2020, and\t421,508\tissued and\t415,048\toutstanding at December 31, 2019\t1\t \tAdditional paid-in capital\t19,459\t7,647\tAccumulated other comprehensive earnings\t337\t134\tRetained earnings\t6,792\t4,984\tTreasury stock, at cost (\t16,770\tand\t6,460\tshares, respectively)\t(\t816\t)\t(\t214\t)\tTotal Centene stockholders' equity\t25,773\t12,551\tNoncontrolling interest\t112\t108\tTotal stockholders' equity\t25,885\t12,659\tTotal liabilities, redeemable noncontrolling interests and stockholders' equity\t$\t68,719\t$\t40,994",
        "timestamp": "2025-03-11_12-18-41"
    },
    "table_json_created": {
        "data": true,
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "trials": {
                    "0": "{\"ASSETS\": {\"Current assets\": {\"Cash and cash equivalents\": [10800, 12123], \"Premium and trade receivables\": [9696, 6247], \"Short-term investments\": [1580, 863], \"Other current assets\": [1317, 1090], \"Total current assets\": [23393, 20323]}, \"Long-term investments\": [12853, 7717], \"Restricted deposits\": [1060, 658], \"Property, software and equipment, net\": [2774, 2121], \"Goodwill\": [18652, 6863], \"Intangible assets, net\": [8388, 2063], \"Other long-term assets\": [1599, 1249], \"Total assets\": [68719, 40994]}, \"LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY\": {\"Current liabilities\": {\"Medical claims liability\": [12438, 7473], \"Accounts payable and accrued expenses\": [7069, 4164], \"Return of premium payable\": [1458, 824], \"Unearned revenue\": [523, 383], \"Current portion of long-term debt\": [97, 88], \"Total current liabilities\": [21585, 12932]}, \"Long-term debt\": [16682, 13638], \"Deferred tax liability\": [1534, 189], \"Other long-term liabilities\": [2956, 1543], \"Total liabilities\": [42757, 28302], \"Commitments and contingencies\": null, \"Redeemable noncontrolling interests\": [77, 33], \"Stockholders' equity\": {\"Preferred stock, $ 0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2020 and December 31, 2019\": [0, 0], \"Common stock, $ 0.001 par value; authorized 800,000 shares; 598,249 issued and 581,479 outstanding at December 31, 2020, and 421,508 issued and 415,048 outstanding at December 31, 2019\": [1, 0], \"Additional paid-in capital\": [19459, 7647], \"Accumulated other comprehensive earnings\": [337, 134], \"Retained earnings\": [6792, 4984], \"Treasury stock, at cost ( 16,770 and 6,460 shares, respectively)\": [-816, -214], \"Total Centene stockholders' equity\": [25773, 12551], \"Noncontrolling interest\": [112, 108], \"Total stockholders' equity\": [25885, 12659]}, \"Total liabilities, redeemable noncontrolling interests and stockholders' equity\": [68719, 40994]}   }"
                },
                "decision": "{\"ASSETS\": {\"Current assets\": {\"Cash and cash equivalents\": [10800, 12123], \"Premium and trade receivables\": [9696, 6247], \"Short-term investments\": [1580, 863], \"Other current assets\": [1317, 1090], \"Total current assets\": [23393, 20323]}, \"Long-term investments\": [12853, 7717], \"Restricted deposits\": [1060, 658], \"Property, software and equipment, net\": [2774, 2121], \"Goodwill\": [18652, 6863], \"Intangible assets, net\": [8388, 2063], \"Other long-term assets\": [1599, 1249], \"Total assets\": [68719, 40994]}, \"LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY\": {\"Current liabilities\": {\"Medical claims liability\": [12438, 7473], \"Accounts payable and accrued expenses\": [7069, 4164], \"Return of premium payable\": [1458, 824], \"Unearned revenue\": [523, 383], \"Current portion of long-term debt\": [97, 88], \"Total current liabilities\": [21585, 12932]}, \"Long-term debt\": [16682, 13638], \"Deferred tax liability\": [1534, 189], \"Other long-term liabilities\": [2956, 1543], \"Total liabilities\": [42757, 28302], \"Commitments and contingencies\": null, \"Redeemable noncontrolling interests\": [77, 33], \"Stockholders' equity\": {\"Preferred stock, $ 0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2020 and December 31, 2019\": [0, 0], \"Common stock, $ 0.001 par value; authorized 800,000 shares; 598,249 issued and 581,479 outstanding at December 31, 2020, and 421,508 issued and 415,048 outstanding at December 31, 2019\": [1, 0], \"Additional paid-in capital\": [19459, 7647], \"Accumulated other comprehensive earnings\": [337, 134], \"Retained earnings\": [6792, 4984], \"Treasury stock, at cost ( 16,770 and 6,460 shares, respectively)\": [-816, -214], \"Total Centene stockholders' equity\": [25773, 12551], \"Noncontrolling interest\": [112, 108], \"Total stockholders' equity\": [25885, 12659]}, \"Total liabilities, redeemable noncontrolling interests and stockholders' equity\": [68719, 40994]}   }"
            },
            "gpt-4o-2024-08-06": {
                "trials": {},
                "decision": null
            }
        },
        "timestamp": "2025-03-12_11-23-56"
    },
    "problems": {
        "data": [],
        "timestamp": "2025-03-12_11-23-56"
    }
}